[1] Gon?觭alves P, Araújo J R, Martel F. Antipsychotics-induced metabolic alterations:
focus on adipose tissue and molecular mechanisms[J]. Eur Neuropsychopharmacol, 2015, 25(1
): 1
[2] 吴仁容,赵靖平.四种抗精神病药对糖代谢及脂代谢的不良影响[J].中华精神科杂志,2005,
38(3):130
[3] 李洁,姚贵忠,刘丽娟,等.非典型抗精神病药物相关代谢不良反应的系统评价和meta-分析[J]
.中国心理卫生杂志,2015,29(3):210
[4] 丁文华,崔东红.免疫相关精神分裂症动物模型研究进展[J].中华行为医学与脑科学杂志,
2013,22(8):764
[5] 张晶晶,谈恒山.黄连素的临床应用研究进展[J].药学与临床研究,2015,23(3):287
[6] Singh I P, Mahajan S. Berberine and its derivatives: a patent review(2009-2012)[J].
Expert Opin Ther Pat, 2013, 23(2): 215
[7] 殷峻,陈名道,唐金凤,等.小檗碱对实验大鼠糖脂代谢的影响[J].中华糖尿病杂志,2004,
12(3):215
[8] 张日东,白瑞苗,魏 敬.黄连素对2型糖尿病患者24h尿微量白蛋白的影响[J].中国中西医结合
肾病杂志,2011,12(1):28
[9] Brusq J M, Ancellin N, Grondin P, etal. Inhibition of lipid synthesis through
activation of AMP kinase: an additional mechanism for the hypolipidemic effects of
berberine[J]. J Lipid Res,2006, 47(6): 1281
[10] 魏敬,蒋建东,吴锦丹.盐酸小檗碱的调脂作用的研究[J].中华糖尿病杂志,2005,13(1):
49
[11] 聂永娥.黄连素治疗高脂血症43例疗效观察[J].实用医技杂志,2005,12(10B):2997
[12] Kulkarni S K, Dhir A. Berberine: a plant alkaloid with therapeutic potential for
central nervous system disorders[J]. Phytother Res, 2010, 24(3): 317
[13] Tarrago T, Kichik N, Segui J, et al. The natural product berberine is a human prolyl
oligopeptidase inhibitor[J]. Chem Med Chem, 2007, 2(3): 354
[14] Chu H, Jin G, Friedman E, et al. Recent development in studies of
tetrahydroprotoberberines: mechanism in antinociception and drug addiction[J].Cell
MolNeurobiol, 2008, 28:491
[15] Potvin S, Stip E, Sepehry A A, et al. Inflammatory cytokine alterations in
schizophrenia: a systematic quantitative review[J]. Biological psychiatry, 2008, 63(8):
801
[16] Antai-Otong D. Adverse drug reactions associated with antipsychotics,
antidepressants, and?mood stabilizers[J]. Nurs Clin North Am,2003, 38(1): 161
[17] Haddad P M, Sharma S G. Adverse effects of atypical antipsychotics : differential
risk and clinical implications[J]. CNS Drugs, 2007, 21(11): 911
[18] Dei Cas A, Spigoni V, Metra M, et al. Insulin-resistance and cardiovascular risk[J].
G Ital Cardiol (Rome), 2010, 11(10 Suppl 1): 93S
[19] Misiak B, Frydecka D, ?覵aczmański ?覵, et al. Effects of second-generation
antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome
components in first-episode schizophrenia patients[J]. Eur J Clin Pharmacol, 2014, 70(12):
1433
[20] 孙杰.黄连素降脂作用的临床观察[J].中国中西医结合杂志,2002,22(4):269
[21] Thongtang N, Diffenderfer M R. Linkage between C-reactive protein and triglyceride-
rich lipoprotein metabolism.[J]. 2013, Metabolism, 2013,62(3): 369
[1]陈清刚,钱 明,王 毅,等.首发精神分裂症患者与超高危人群认知功能的对照研究[J].天津医科大学学报,2014,20(03):216.
CHEN Qing gang,QIAN Ming,WANG Yi,et al.Control study of cognitive function in ultra-high risk population of schizophrenia and first-episode schizophrenia patients[J].Journal of Tianjin Medical University,2014,20(02):216.
[2]程 娟,徐小童,毛富强,等.内观认知疗法改善偏执型精神分裂症康复期社会功能的研究[J].天津医科大学学报,2014,20(04):313.
[3]田 丽,杨 媛,胡永梅.首诊精神分裂症患者的病耻感与社会功能的关系研究[J].天津医科大学学报,2014,20(06):480.
[4]张 静,赵永萍,贾 琼,等.黄连素对利培酮治疗精神分裂症患者症状及糖脂代谢的影响[J].天津医科大学学报,2016,22(04):338.
[5]李慧慧,毛富强,韩邵明,等.内观认知疗法对精神分裂症患者服药依从性的影响[J].天津医科大学学报,2017,23(06):548.
LI Hui-hui,MAO Fu-qiang,HAN Shao-ming,et al.Effect of Naikan CognitiveTherapy on medication adherence in schizophrenic patients[J].Journal of Tianjin Medical University,2017,23(02):548.
[6]杜 彬,杨建立.氟西汀辅助治疗前后精神分裂症患者外周血miR-181b
表达差异研究[J].天津医科大学学报,2019,25(01):63.
DU Bin,YANG Jian-Li.Study on the difference of miR-181b expression in patients with schizophrenia before and after fluoxetine treatment[J].Journal of Tianjin Medical University,2019,25(02):63.
[7]崔 鹏,杨建立.奥卡西平治疗的精神分裂症兴奋激越患者的效果及对血清Hcy的影响[J].天津医科大学学报,2019,25(01):66.
CUI Peng,YANG Jian-Li.Effect of oxcarbazepine on patients with schizophrenia and excitement and its effect on serum Hcy[J].Journal of Tianjin Medical University,2019,25(02):66.
[8]马晓雷,孙焕君,和西波,等.中国精神分裂症患者认知能损害性别差异的P300证据[J].天津医科大学学报,2019,25(02):167.
MA Xiao-lei,SUN Huan-jun,HE Xi-bo,et al.P300 evidence for the gender difference in cognitive impairment in Chinese patients with schizophrenia[J].Journal of Tianjin Medical University,2019,25(02):167.